Upload
ledat
View
216
Download
4
Embed Size (px)
Citation preview
Dr. Elizabeth A. Juma
Academic and professional quali�cations
YEAR QUALIFICATION 2001 – 2004 Master of Medicine in Obstetrics and Gynaecology at the University of Nairobi 1990 – 1997 Bachelor of Medicine and Bachelor of Surgery (MB.Ch.B) University of Nairobi Medical
School. Best overall student class of 1997. OTHER TRAINING
2011 Currently undertaking an online Master of Public Health course at the University of Liverpool
2012 Completed a 6‐week course on strategic leadership and development at the
Kenya Institute of Administration 2006 ‐ 2009 Attended the annual four day WHO/TDR GCP refresher course for TDR Clinical
Monitors July 2006 Attended a two day KEMRI/University of Malawi Course on Biomedical Ethics,
Kisumu Kenya August 2005 Attended a 10 days WHO/TDR Good Clinical Practice course for potential Clinical
Monitors March 2005 Attended a 3 day course on Good Clinical Practice, Kisumu Kenya April 2005 Attended a 7‐ Day intensive PRACTIHC workshop on the Design and Conduct of
Clinical Trials, Cape Town South Africa November 2000 3 week course on research methodology and obtained a Certi�cate in Research
Methodology – Centre for Health and Population Research, ICDDR, B August 2000 Attended a one month course on reproductive health research methods and
obtained a certi�cate in Reproductive Health Research Methodology from the Reproductive Health Research Unit, Johannesburg SA.
Areas of expertise Epidemiology and Public Health Programme Management Strategic Planning
Monitoring and Evaluation Clinical Trials Investigator Clinical Monitor and Auditor
Work experience
1. CURRENT POSITION From October 2011, I re‐joined the Kenya Medical Institute, Centre for Global Health Research as a Senior Research O�cer. My major interests are in phase I‐IV malaria clinical trials and operations research to provide evidence for the successful implementation of public health interventions.
2. PROGRAMME MANAGER FOR THE NATIONAL MALARIA CONTROL PROGRAMME FROM 2008 ‐ 2011 I joined the National Malaria Control Program, Ministry of Public Health and Sanitation in September 2008 as the programme manager, have been seconded from the Kenya Medical Research Institute. Responsibilities
� Development and review of policies, strategies and guidelines for malaria control in Kenya � Coordination of partners and stakeholders including civil society, private sector and key non‐
health government sectors in the development process of these strategic documents and implementation plans.
� Management activities including the development of annual work plans for the programme from the strategic plan and working with districts to develop annual work plans and budgets for implementation
� Implementation the regular documentation of program implementation achievements and reporting
� Resource mobilization (for example the development of Global Fund Round 9 and Round 10 proposals for malaria, and development of proposals to DFID and World Bank to support interventions) and �nancial management of resources used in the implementation of interventions for malaria control.
Grants Managed At the national programme I was responsible for the management of a grant portfolio totaling US $ 100 million for activities implemented between 2008 and 2011. These were funds drawn from the Global Fund to Fight Aids Tuberculosis and Malaria and Government of Kenya Funds.
Achievements
1. In 2009, was the coordinator of the Kenya malaria programme review, one of the �rst global malaria programme reviews. I was also part of the team that developed the WHO guidelines for malaria programme reviews.
2. Development of a National Malaria Policy and policy implementation guidelines for all intervention areas
3. Developed a National Malaria Epidemiological Strati�cation Map to guide the targeted implementation of interventions
4. Developed National Malaria Strategic Plan and M&E plan for the implementation in line with global malaria action plan
5. In 2010‐2011, Kenya achieved universal coverage with vector control interventions for population at risk and universal access to free or a�ordable treatment with artemisinin combination treatments (ACTs)
6. Coordinated a successful partnership in malaria control in Kenya including bilateral and multilateral donor agencies, various programmes including maternal and child health, research
and academic institutions, civil society and faith based organizations, private sector agencies and communities.
7. Actively participated in the successful mobilization of US$ 170 million from the Global Fund and DFID to sustain universal coverage with malaria control interventions and introduce diagnosis bases case management between 2011 and 2015.
3. WHO/TDR CLINICAL MONITOR AND AUDITOR FROM 2005
I have been a WHO Clinical Trials Monitor from 2005 and an auditor since 2008. Currently I am the Regional Clinical Coordinator for clinical trials in Anglophone Countries. I have participated in the audits of 2 clinical trials conducted in Africa. Among the studies monitored and or coordinated are:
1. Feasibility, acceptability and costs of a community‐based diagnostic and treatment package for malaria of varying degrees of severity in sub‐ Saharan Africa from 2009 to date.
2. An assessment of the use of RDT in the context of HMM with ACTs, Uganda from 2009 to date.
3. An evaluation of the impact of early initiation of Highly Active Anti‐Retroviral Therapy (HAART) on Tuberculosis (TB) treatment outcomes for TB patients co‐infected with Human Immunode�ciency Virus (HIV) from 2007 to 2009
4. Two‐arm, single‐blind, randomised comparison of four �xed‐dose combinations versus standard treatment with separate anti‐TB drugs for treatment of pulmonary tuberculosis from 2007 to 2008
5. A double blind, randomized, controlled, dose escalation phase Ib �eld trial in 12 to 24 month old children in Korogwe, Tanzania to evaluate the safety and immunogenicity of the Plasmodium falciparum Merozoite Surface Protein‐3 Long synthetic peptide (MSP 3) adjuvanted in aluminium hydroxide versus hepatitis B from 2007 to 2008
6. E�ectiveness and pharmacovigilance of Lapdap and Coartem for the treatment of uncomplicated falciparum malaria in northeastern Tanzania from 2005 to 2006
7. Evaluation of neonatal immunization with pneumococcal conjugate vaccine from 2006 to 2008
4. RESEARCH SCIENTIST FROM 1999 TO 2008 2007 – 2008 Successfully completed 2 clinical trials as Principal Investigator and Co‐ Investigator:
1. “A randomized open‐label trial of the e�cacy of artemether‐lumefantrine suspension compared with artemether‐lumefantrine tablets for the treatment of uncomplicated plasmodium falciparum malaria in children less than �ve years in Western Kenya” 2. “Open‐label randomized clinical trial of pharmacokinetics, e�cacy, and tolerability of the �xed‐dose artesunate/amodiaquine (AS/AQ) combination therapy versus both drugs administered separately for treatment of uncomplicated falciparum malaria in Kenya.”
2005 – 2007 From January 2005 to March 2007, I was co‐investigator in a GCP “Randomized,
investigator‐blinded, multicenter, parallel‐ group study to compare e�cacy, safety and tolerability of Coartem® dispersible tablet formulation vs. Coartem® 6‐dose crushed tablet in the treatment of acute uncomplicated Plasmodium falciparum malaria in infants and children”
2005 – 2006 From November to March 2006 I was the Kenyan Investigator of a Multi – centre randomized trial in Africa comparing e�cacy of sulphametopyrazine‐pyrimethamine and amodiaquine combination with artemether‐lumefantrine in the treatment of uncomplicated P. falciparum malaria in children under 5 years. The Kenyan phase of this trial was prematurely stopped due to the change of antimalarial treatment policy in 2006.
2005 From May to June 2005, I was a sub‐investigator in a GCP multi‐centre, phase II/III
randomized, double blind, placebo controlled trial of azithromycin plus chloroquine versus me�oquine in the treatment of uncomplicated falciparum malaria in Africa.
2004 – 2005 From June 2004 to May 2005, I was a co‐Investigator in a Comparative study of the
safety and e�cacy of artemether‐lumefantrine and amodiaquine/artesunate in children under �ve in endemic and epidemic malaria zones in Kenya. As an investigator, I identi�ed sta�, conducted training, and provided supervision during the conduct of the trial at the 3 study sites, performed data cleaning and analysis and provided a report to the Ministry of Health. A technical report was produced for the Ministry of Health .
2004 Joined the Kenyan Ministry of Health Antimalarial Drug Policy Technical Working Group,
for Malaria in Pregnancy. Our mandate was to develop new malaria treatment guidelines for health workers in Kenya. The new policy was implemented in July 2006.
2001 – 2004 Underwent postgraduate training in Obstetrics and Gynaecology at the University of
Nairobi ‐ graduated in May 2004. 2000 From March to December 2000, Investigator, Prevention of Mother to Child
transmission of HIV using AZT in women in a rural community in Western Kenya KEMRI/JICA project. Did a qualitative study on utilization of maternity services by women in the study cohort and presented it as part of my theses for the degree of Masters of Medicine in Obstetrics and Gynaecology.
1999 ‐ 2000 Medical O�cer providing clinical care for trial participants in a GCP Phase IV
Tafenoquine Clinical trials, Western Kenya with the Walter Reed Project. 1999 ‐ 2008 Research O�cer at the Kenya Medical Research Institute from November 1999 1998 Part time Medical O�cer at the Family Planning Association of Kenya Clinic in Nakuru.
Duties included provision of contraception services and other medical care for clients seeking contraception
Member of Data Safety Monitoring Boards I have served as a member of the data safety monitoring boards for two studies:
1. Safety & acceptance of 62% & 15% ethanol in emollient gel as topical male microbicides 2008‐9
2. An expanded phase I randomized placebo controlled trial of the safety and tolerability of 3% w/w SPL7013 Gel (VivaGel™) in healthy young women when administered twice daily for 14 days 2007‐2008
5. MEDICAL OFFICER 1997 TO 1999 From 1997 to 1999 I was a Medical O�cer intern and subsequently a medical o�cer in the Department of Obstetrics and Gynaecology Provincial General Hospital, Nakuru. Duties performed included daily
rounds in obstetrics and gynaecology, performing emergency surgeries and running the Antenatal and Gynaecology outpatient clinics 6. CONSULTANCIES
SERVICES PERFORMED EMPLOYER’S NAME AND ADDRESS POINT OF CONTACT &TELEPHONE #
Dates of Employment Days at Rate
Daily Rate In Dollars From To
Review and consolidation of National malaria supervision reports and Annual Malaria report
ICF Macro Inc. 11785 Beltsville Drive, Suite 300 Calverton, MD 20705
March 2012
April 2012
22 330
Ghana Country Case Study for the end line evaluation of the a�ordable medicines facility for malaria (AMFm)
ICF Macro Inc. 11785 Beltsville Drive, Suite 300 Calverton, MD 20705
November 2011
January 2012
22 400
Review of WHO Handbook of Severe Malaria
Global Malaria Programme/World Health Organization, Avenue Appia 20 1211 Geneva 27
October 2011
November 2011
20 300
Clinical Trials Monitoring Coordination TDR/World Health Organization Avenue Appia 20 1211 Geneva 27 SWITZERLAND
May 2010 May 2011 16 300
External consultant – Botswana Malaria Programme Review
WHO/IST/ESA PO Box BE 773 Belvedere, Harare, ZIMBABWE
August 2009
August 2009
14 250
WHO guidelines for Malaria Programme Reviews
WHO/IST/ESA PO Box BE 773 Belvedere, Harare, ZIMBABWE May 2009 May 2009 5 250
National Malaria Policy Document WHO‐Kenya, P. O. Box 45335, 00100 Nairobi, KENYA
December 2009
April 2010 25 105
Contributions to books manuals and public reports WHO Regional O�ce for Africa (2012) Manual for Developing aNational Malaria Strategic Plan. Brazaville, Republic of Congo, WHO‐AFRO. WHO (2010) Malaria Programme Reviews: A manual for reviewing the performance of malaria control and elimination programmes TRIAL EDITION. Geneva, World Health Organization.
Elizabeth Juma Kalu Akpaka Shiva Murugasampillay Charles Obonyo Stephen Munga Andrew Wamari Willis Akhwale and S.K. Sharif. The Kenya Malaria Program Performance Review 2009. Ministry of Public Health and Sanitation, Nairobi, August 2009 Division of Malaria Control. Kenya National Malaria Policy. 1st Edition 2010. Ministry of Public Health and Sanitation, Nairobi, April 2010. Division of Malaria Control. Kenya National Malaria Strategy and Monitoring & Evaluation Plan 2009‐2017. Ministry of Public Health and Sanitation, Nairobi, July 2009. Division of Malaria Control. National guidelines for the diagnosis, treatment and prevention of malaria in Kenya. 3rd Edition. Ministry of Public Health and Sanitation, Nairobi, May 2010. Snow RW, Okiro EA, Noor AM, Munguti K, Tetteh G and Juma E. The coverage and impact of malaria intervention in Kenya 2007‐2009. Ministry of Public Health and Sanitation & Management Sciences for Health/Strengthening Pharmaceutical Systems Program, Nairobi, November 2009.
Memusi D, Nyandigisi A, Mbithi A, Shieshia M, Muturi A, Zurovac D, Juma E. Monitoring outpatient malaria case management following implementation of new diagnostic and treatment policies in Kenya. Division of Malaria Control, Ministry of Public Health and Sanitation, Nairobi, June 2010. Publications in peer reviewed journals
1. Christine Manyando, Kassoum Kayentao, Umberto D'Alessandro, Henrietta U Okafor, Elizabeth Juma and Kamal Hamed. (2012). ‘A systematic review of the safety and e�cacy of artemether‐lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.’ Malaria Journal. 2012 May 1; 11(1):141.
2. Gillian H. Ice, Aalyia F.A. Sadruddin, Amy Vagedes, Jaja Yogo and Elizabeth Juma (2012) ‘Stress associated with caregiving: An examination of the stress process model among Kenyan Luo elders’ Social Science & Medicine, Volume 74, Issue 12, Pages 2020‐2027
3. Charles O Obonyo and Elizabeth A Juma (2012) ‘Malaria Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta‐analysis’ Malaria Journal, 11:2 doi:10.1186/1475‐2875‐11‐2
4. Nyandigisi A, Memusi D, Mbithi A, Ang’wa N, Shieshia M, Muturi A, Sudoi R, Githinji S, Juma E, and Zurovac D. (2011) Malaria Case‐Management following Change of Policy to Universal Parasitological Diagnosis and Targeted Artemisinin‐Based Combination Therapy in Kenya. PLoS ONE 6(9): e24781. doi:10.1371/journal.pone.0024781
5. Ice, G. H., Heh, V., Yogo, J. and Juma, E. (2011), Caregiving, gender, and nutritional status in Nyanza Province, Kenya: Grandmothers gain, grandfathers lose. American Journal of Human Biology, 23: 498–508. doi: 10.1002/ajhb.21172
6. Sandra A Mudhune, Emelda A Okiro, Abdisalan M Noor, Dejan Zurovac, Elizabeth Juma, Sam A Ochola and Robert W Snow. 2011 The clinical burden of malaria in Nairobi: a historical review and contemporary audit. Malaria Journal 2011, 10:138
7. Elizabeth Juma and Dejan Zurovac. 2011 Changes in health workers' malaria diagnosis and treatment practices in Kenya. Malaria Journal 2011, 10:1
8. Caroline W Gitonga, Peris N Karanja, Jimmy Kihara, Mariam Mwanje, Elizabeth Juma, Robert W Snow, Abdisalan M Noor & Simon Brooker. Implementing the �rst national school malaria survey in Kenya: study design, process and main �ndings Malaria Journal 2010, 9:306
9. Jullien V, Ogutu B, Juma E, Carn G, Obonyo C, Kiechel JR. Population pharmacokinetics and
pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate‐amodiaquine combination therapy. Antimicrobial Agents and Chemotherapy. 2010 Jun;54(6):2611‐7.
10. Gillian H. Ice, Jaja Yogo, Victor Heh, and Elizabeth Juma. (2010) Impact of Caregiving on health and wellbeing of Luo Grandparents. Research on Aging 32 (1): 44 – 60
11. Zidron, A. M., Juma, E. and Ice, G. H. (2009), Does being an orphan decrease the nutritional status of Luo children?. American Journal of Human Biology, 21: 844–851. doi: 10.1002/ajhb.20902
12. Abdisalan M Noor, Peter W Gething, Victor A Alegana, Anand P Patil, Simon I Hay, Eric Muchiri, Elizabeth Juma and Robert W Snow (2009) Risks of Malaria Infection in Kenya in 2009. BMC Infectious Diseases 2009, 9:180
13. Horwitz, Shawn; Yogo, Jaja; Juma, Elizabeth; Ice, Gillian. Care‐giving and Cardiovascular Disease
Risk Factors in Male and Female Luo Elders from Kenya (2009) Annals of Human Biology, 36:4,400 — 410
14. Elizabeth A. Juma, Charles O. Obonyo, Willis S Akhwale, Bernhards R Ogutu. A randomized open‐label comparative e�cacy trial of artemether‐lumefantrine powder for suspension (Co‐artesiane®) versus artemether‐lumefantrine (Coartem®) tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya Malar J. 2008 Dec 22;7:262)
15. Salim Abdulla, Issaka Sagara, Ste�en Borrmann, Umberto D’Allessandro, Raquel González, Mary
Hamel, Bernhards Ogutu, Andreas Mårtensson, John Lyimo, Hamma Maiga, Philip Sasi, Alain Nahum, Quique Bassat, Elizabeth Juma, Lucas Otieno, Anders Björkman, Hans Peter Beck, Kim Andriano, Marc Cousin, Gilbert Lefèvre, David Ubben, Zul Premji. “E�cacy and safety of artemether‐lumefantrine dispersible tablet in African infants and children with uncomplicated malaria: a randomised, investigator‐blinded, multi‐centre comparison with the crushed commercial tablet (2008) Lancet 22;372(9652):1819‐27
16. Gillian Ice, Amy Zidron and Elizabeth Juma (2008) Health and health perceptions among Kenyan
grandparents. Journal of Cross Cultural Gerontology 23 (2): 111‐129 17. Charles O. Obonyo, Elizabeth A. Juma; Bernhards R. Ogutu; John M. Vulule; Joseph Lau (2007)
Amodiaquine combined with sulfadoxine‐pyrimethamine versus artemisinin‐based combinations for the treatment of uncomplicated falciparum malaria in Africa: A meta‐analysis Trans. R. Soc. Trop. Med. Hyg. 101; 117—126
18. Obonyo CO, Juma EA. Clindamycin plus quinine for the treating uncomplicated malaria. The
Cochrane Library 2006, Issue 3.
19. Juma EA. (2005) Malaria in Pregnancy. Medicine Digest April 2005
20. Juma EA, Mugo NR, Altieri A, Smith J. (2004) A Review of Gestational Trophoblastic Diseases at the Kenyatta National Hospital, 1998 – 2001. J Obstet Gynaecol East C Afr 2004 March; 17(1):
21. EA Juma, FN Odongo Odiyo. (2000) Maternal Mortality at the Provincial General Hospital, Nakuru. East Afr Med J; 77 (7): 382 – 385